SEC Form 10-Q filed by MeiraGTx Holdings plc
$MGTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/31/2024 | $36.00 | Buy | Chardan Capital Markets |
Chardan Capital Markets resumed coverage of MeiraGTx with a rating of Buy and set a new price target of $36.00
4 - MeiraGTx Holdings plc (0001735438) (Issuer)